Pricing Log in Create free account
Sunday 25 October 2026 Export MRK’s income statement to Excel — free account

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS fell 130.7%, free cash flow grew 77.0% and total debt rose 50.4%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for five.

145.27 1.97 −1.34%
Market cap
$363.3B
P/E
116×
Fwd P/E
106×
Dividend yield
2.35%
F-score
4/9
Altman Z
3.77
Beneish M
−2.27
Dividend safety
74/100
Overview Business Profile Earnings & Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Segments Filings 10-Q 10-K

Merck & Co., Inc. (MRK) P/E ratio

Alert me on P/E ratio

As of 23 October 2026, Merck & Co., Inc. (MRK) trades at a P/E ratio of 116×. Over the past ten years it has ranged from 10.7× (May 2025) to 943× (March 2024); the current reading is higher than 94% of that period. That is above the Drug Manufacturers General industry median of 25.4× and above the Healthcare sector median of 23.7×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 14.5× (2.18%)
FY2024 14.8× (98.17%)
FY2023 809× 4,070.18%
FY2022 19.4× 30.59%
FY2021 14.9× (47.29%)
FY2020 28.2× 23.71%
FY2019 22.8× (27.52%)
FY2018 31.4× (45.52%)
FY2017 57.7× 40.63%
FY2016 41.0× 26.97%

Quarterly newest first

Period P/E ratio Change
Jun 2026 103× 203.38%
Mar 2026 33.9× 134.35%
Dec 2025 14.5× 30.41%
Sep 2025 11.1× (9.10%)
42 more quarters

Against its own ten years

Low 10.7× High 943×
Ten-year median 24.5×
Current reading's percentile 93

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.5×
NVS Novartis AG compare 22.7×
AZN AstraZeneca PLC compare 25.4×
AMGN Amgen Inc. compare 27.1×
JNJ Johnson & Johnson compare 30.6×
PFE Pfizer Inc. compare 39.5×
ABBV AbbVie Inc. compare 80.7×
MRK Merck & Co., Inc. 116×
Drug Manufacturers General industry median 25.4×
Healthcare sector median 23.7×
Market median 18.4×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on MRK